OpenVSafe by OpenVAERS
Search V-safe

DBT-18135-46890

1 vaccination 4 coded responses 10 check-ins 4 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
180 / PA
Registered
2022-06-26
Relationship
Child or adolescent in my care
Guardian
MYM-24523-99735
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2398031 (opens in a new window) high 10 / 11 3 8 of 26 VAERS symptoms same dose (1) PA matches 2022-06-25 / 2022-06-25 / 2022-08-01
received the same day as the last call
case 900305

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2022-06-25
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-26
    Registered in v-safe
  3. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Fever · Sleepiness, Irritability/crying
    Under 3 check-in
  5. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school
    Under 3 check-in
  6. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Fever · Sleepiness, Irritability/crying · Be unable to work or attend school
    Under 3 check-in
  7. 2022-07-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite, Diarrhea · Be unable to work or attend school
    Under 3 check-in
  8. 2022-07-02
    Survey response — day 7, dose 1, under 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Fever · Sleepiness · Be unable to work or attend school
    Free text: Congestion and coughing
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-07-09
    Survey response — day 14, dose 1, under 3
    MedDRA: Office visit, Rash — Feeling: Poor · Be unable to work or attend school
    Free text: Full-body rash for 2 days so far believed to be a viral exanthem rash (source: multiple doctors).
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-07-23
    Survey response — day 28, dose 1, under 3
    MedDRA: Cough, Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat, cough
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-07-31
    Survey response — day 35, dose 1, under 3
    MedDRA: Cough, Headache, Lethargy, Medical counselling, Mouth ulceration, Pain, Pyrexia, Rash, Respiratory tract congestion, Sneezing, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Had a fever nearly every day with several days over 103 and two days over 105. Rectal temp was 102.7 two days ago. No fever in the last 36 hours. Has experienced lethargy, headache, pain, oral sore, rashes, sneezing, cough, congestion, vomiting, etc. · Healthcare visit (other): In home treatment from medical professional parents.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-07-31
    Report sent to call center — day 35, dose 1, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  13. 2022-08-01
    Call successful
    Completed over the phone
  14. 2022-08-07
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-06-25Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 12 (Under 3) — day 7, dose 1, under 3

2022-07-02

Systemic reaction (other): Congestion and coughing

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-09

Symptoms: Full-body rash for 2 days so far believed to be a viral exanthem rash (source: multiple doctors).

Release 12 (Under 3) — day 28, dose 1, under 3

2022-07-23

Symptoms: Sore throat, cough

Release 12 (Under 3) — day 35, dose 1, under 3

2022-07-31

Symptoms: Had a fever nearly every day with several days over 103 and two days over 105. Rectal temp was 102.7 two days ago. No fever in the last 36 hours. Has experienced lethargy, headache, pain, oral sore, rashes, sneezing, cough, congestion, vomiting, etc. cut off by CDC
Healthcare visit (other): In home treatment from medical professional parents.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
SDCough · · ✓
SDHeadache · · ✓
SDLethargy · · ✓
SDMouth ulceration · · ✓
SDOffice visit · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDPyrexia · · ✓
SDRash · · ✓
SDRespiratory tract congestion · · ✓
SDSneezing · · ✓
SDVomiting · · ✓
SROCough · · ✓
SRORespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release